optic neuropathy semaglutide Dose-dependent Risk for Ischemic Found with Use of semaglutide linked to

Lumbrokinase is marketed as promoting healthy circulation and supporting heart health

Mounjaro and PCOS: What the Evidence Says Mounjaro (tirzepatide) is not licensed to treat PCOS/PMOS

Structural differences between GLP-1 analogues and individual patient factors such as baseline gastric motility also influence tolerability

When we stratified patients by history of renal disease, the use of the GLP-1 receptor agonist-SGLT-2 inhibitor combination in patients with a history of renal disease was associated with a lower hazard ratio for major adverse cardiovascular events (0.41, 0.18 to 0.94) compared with patients without previous renal disease (0.80, 0.57 to 1.12

Here are some of the most surprising and significant benefits of GLP-1s that are reshaping modern medicine